Selbyville, Delaware, Dec. 05, 2022 (GLOBE NEWSWIRE) --
The AI in healthcare market value is set to surpass over USD 70 billion by 2032, according to a new research report by Global Market Insights Inc.
Increasing reliance on digital assistants and other advanced technologies will proliferate the deployment of AI in healthcare. As administrative workloads continue to rise, hospitals and medical practices are leveraging voice-enabled digital assistants to reduce physician burnout. Apart from easing the administrative burden, healthcare AI is well-placed to revolutionize medical research, considering its ability to rapidly evaluate deep datasets. With the rise in clinical research associated with disease development and diagnosis, the application potential of artificial intelligence in healthcare will further expand globally.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1557
Despite these advances, AI technology still faces some technical limitations. As the technology is dependent on data networks, the systems are susceptible to security threats. Such drawbacks may limit the use of AI across the healthcare industry to some extent. However, the capability to aid healthcare professionals in diagnosing and addressing medical issues to optimize critical decision-making is likely to promote its adoption in real-time health data analytics applications.
High chronic disease burden boost AI use in therapy planning applications
Artificial intelligence in healthcare market from therapy planning applications is set to depict over 28% CAGR through 2032. The growing datasets of digital information related to patient health and the increasing number of cancer patients adopting radiation therapy as treatment are among the major growth drivers. Based on data from the National Cancer Institute, over 60% of cancer patients require radiation therapy. Since AI-based tools can make radiation treatment planning more effective without a heavy dependence on CT, healthcare AI is anticipated to gain significant momentum as a therapy planning tool.
Browse key industry insights spread across 139 pages with 79 market data tables & 11 figures & charts from the report, “Artificial Intelligence in Healthcare Market Statistics By Application, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/healthcare-artificial-intelligence-market
Key reason for AI in healthcare market growth:
- Increasing scope of future applications
- Big data analytics advancements
- Favorable funding scenario in Singapore and China
- Potential to boost the quality-of-care delivery
Healthcare artificial intelligence market from precision medicine and other applications was valued at over USD 141.5 million in 2022. Other applications include dosage error reduction, digital consultation, AI-assisted robotic surgery, and precision medicine. Based on data from the Genetic and Rare Diseases Information Center, 30 million or 1 in 10 people in the U.S. have a rare disease. This will foster the adoption of precision medicine to reduce disease burden and consequently boost the implementation of artificial intelligence and machine learning in healthcare.
Government investments to promote healthcare AI development in North America
North America region held over 50% share of the global artificial intelligence in healthcare market in 2022, on account of the increasing government funding for healthcare following the COVID-19 outbreak. The strong presence of tech companies including Microsoft Corporation, IBM Corporation, and NVIDIA Corporation will contribute to the usage of healthcare AI in the region.
Request for customization of this research report @ https://www.gminsights.com/roc/1557
Mergers and acquisitions by major players to define market landscape
iCarbonX, Atomwise, Inc., Cyrcadia Health Inc., Modernizing Medicine, IBM Corporation, Insilico Medicine Inc, NVIDIA Corporation, Sophia Genetics, Virgin plus, and Nanox are among the key players operating in the market. These companies are emphasizing strategic mergers and acquisitions to increase their presence in the global market.
Partial Table of Contents (ToC) of AI in healthcare market research report:
Chapter 3 Healthcare Artificial industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2023 - 2032
3.3 Industry impact forces
3.4 Growth potential analysis
3.5 COVID-19 impact analysis
3.6 Patent analysis
3.7 Start-up scenario
3.8 Healthcare artificial intelligence projects
3.9 Medical and technological advancements
3.10 Regulatory landscape
3.11 Porter’s analysis
3.12 PESTEL analysis
Browse Our Reports Store - GMIPulse @ https://www.gminsights.com/gmipulse
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
